| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
U.S. peanut allergy rates are falling under updated feeding guidance as Robert F. Kennedy Jr. questions long-held explanations ...
HC Wainwright & Co. analyst Andrew S. Fein maintains DBV Technologies (NASDAQ:DBVT) with a Buy and raises the price targ...